Anti-inflammatory peptides
    3.
    发明授权
    Anti-inflammatory peptides 有权
    抗炎肽

    公开(公告)号:US08188053B2

    公开(公告)日:2012-05-29

    申请号:US12086210

    申请日:2006-12-04

    CPC classification number: C12N9/0036 A61K38/00

    Abstract: The present invention relates, inter alia, to a method of ameliorating an inflammatory skin condition. Thus, the present invention provides a peptide that includes the amino acid sequence KMIKP (SEQ ID NO: 20), wherein the peptide includes no more than 70 amino acids and wherein the peptide is capable of inhibiting allergen induced Langerhans cell migration, and wherein the peptide is not that depicted in SEQ ID NO. 19. The present invention also relates to the use of a peptide that includes the amino acid sequence KMIKP (SEQ ID NO: 20), wherein the peptide includes no more than 100 amino acids, and wherein the peptide is capable of inhibiting allergen induced Langerhans cell migration, in the manufacture of a topical medicament for the treatment of an inflammatory skin condition.

    Abstract translation: 本发明尤其涉及一种改善炎性皮肤病症的方法。 因此,本发明提供了包含氨基酸序列KMIKP(SEQ ID NO:20)的肽,其中所述肽包含不超过70个氨基酸,并且其中所述肽能够抑制变应原诱导的朗格汉斯细胞迁移,并且其中 肽不是SEQ ID NO: 本发明还涉及包含氨基酸序列KMIKP(SEQ ID NO:20)的肽的用途,其中所述肽包含不超过100个氨基酸,并且其中所述肽能够抑制变应原诱导的朗格汉斯 在制备用于治疗炎性皮肤病症的局部药物中的细胞迁移。

    Anti-Inflammatory Peptides
    8.
    发明申请
    Anti-Inflammatory Peptides 有权
    抗炎肽

    公开(公告)号:US20090253631A1

    公开(公告)日:2009-10-08

    申请号:US12086210

    申请日:2006-12-04

    CPC classification number: C12N9/0036 A61K38/00

    Abstract: The present invention relates, inter alia, to a method of ameliorating an inflammatory skin condition. Thus, the present invention provides a peptide that includes the amino acid sequence KMIKP (SEQ ID NO: 20), wherein the peptide includes no more than 70 amino acids and wherein the peptide is capable of inhibiting allergen induced Langerhans cell migration, and wherein the peptide is not that depicted in SEQ ID NO. 19. The present invention also relates to the use of a peptide that includes the amino acid sequence KMIKP (SEQ ID NO: 20), wherein the peptide includes no more than 100 amino acids, and wherein the peptide is capable of inhibiting allergen induced Langerhans cell migration, in the manufacture of a topical medicament for the treatment of an inflammatory skin condition.

    Abstract translation: 本发明尤其涉及一种改善炎性皮肤病症的方法。 因此,本发明提供了包含氨基酸序列KMIKP(SEQ ID NO:20)的肽,其中所述肽包含不超过70个氨基酸,并且其中所述肽能够抑制变应原诱导的朗格汉斯细胞迁移,并且其中 肽不是SEQ ID NO: 本发明还涉及包含氨基酸序列KMIKP(SEQ ID NO:20)的肽的用途,其中所述肽包含不超过100个氨基酸,并且其中所述肽能够抑制变应原诱导的朗格汉斯 在制备用于治疗炎性皮肤病症的局部药物中的细胞迁移。

Patent Agency Ranking